Download PDF
SARcode Bioscience, Inc., is a privately held, venture-backed biopharmaceutical company based in Brisbane, CA.

SARcode Bioscience is developing novel molecules that specifically target chronic T-cell mediated inflammation in ophthalmic and dermatologic disease.
Lifitegrast mechanism of action
March 5, 2012

Last Patient Enrolled in Pivotal Dry Eye Study; Generic Name Adopted for SAR 1118